Botulinum toxin - Therapeutic use - Rating of
Semen parameters and seminal plasma protein and biochemical profi les of dogs with benign prostatic hyperplasia after botulinum toxin type A intraprostatic injection
... Botulinum toxin type A is the strongest biological neurotoxin known to man, however in our study, as well as in previous ones the therapeutic use of BT-A for BPH treatment showed to be ...
6
Molecular targets of botulinum toxin serotypes A and C: an experimental in-vitro and in-vivo study
... mechanism of the different serotypes, the coreceptors for BoNT/C and BoNT/D have not yet been ...domain of BoNT/C, indicating other possible binding sites for gangliosides and carbohydrates ...subserotypes ...
95
Botulinum toxin-A injections as therapy for chronic painful post-traumatic trigeminal neuropathy: case report
... An inferior alveolar blockade was done with lidocaine; which resulted in reduction in pain intensity (VAS: 0). Thus, topical application of 0.025% capsaicin (four times a day for 5 minutes) and nortriptyline 10mg ...
5
Combined treatment with botulinum toxin and hyaluronic acid to correct unsightly lateral-chin depression*
... and use 2 to 3 units of toxin per point (Figure ...displacement of Bichat fat. We draw a line at the edge of the jaw bring- ing together the two anterior lines, and 2 cm above this we ...
3
Botulinum toxin as a treatment for short bowel syndrome in rats
... usefulness of the BAC experimental model for the comprehension of the role of the enteric nervous system in intestinal adaptations after extensive resections, translating these promising findings ...
5
Botulinum toxin for modulating the muscle strength of patients rehabilitated with zygomatic implants
... activity of masseter and anterior temporal muscles based on BTX-A therapy in patients rehabilitated with total prostheses on zygomatic ...object of the study was a sample of 20 individuals subjected ...
8
Lower facial remodeling with botulinum toxin type A for the treatment of masseter hypertrophy
... num toxin A (Dysport, Ipsen Limited, Wrexham, UK), BTXA (Prosigne, Lanzhou Institute, Lanzhou, China), incobotulinum toxin A (Xeomin, Mers Pharmaceuticals, Frankfurt AM Main, Germany), and Neuronox (Medytox ...
7
Botulinum toxin A (BT-A) versus low-level laser therapy (LLLT) in chronic migraine treatment: a comparison
... Classification of Headache Disorders (International Headache Society, 2014), having presented with headache more than 15 ...analgesic use, those overusing medication for head- ache control were excluded, ...
5
Clinical features and treatment with botulinum toxin in blepharospasm: a 17-year experience
... Diagnosis of previous psychiatric disease occurred in 8% of subjects, predominantly depression; 12 ...previous use of neuroleptic ...coexistence of both diseases (BPS and MG) is a valid ...
5
Botulinum toxin for hereditary spastic paraplegia: effects on motor and non-motor manifestations
... could use more detailed techniques (such as gait analysis) to deter- mine more precisely the doses and muscles to be injected in each ...combination of Btx-A and rehabilita- tion significantly improves the ...
6
The positive effect of Botulinum toxin type A on the viability of random flap in tobacco exposed in rats
... We consider these results methodological steps to define this tobacco exposure model as feasible and reproducible. Our study had some limitations; we did not assess the pathophysiology of tobacco smoke exposure. ...
4
Histological and immunohistochemical findings of the action of botulinum toxin in salivary gland: systematic review
... treatment of sialorrhea is necessary for the constant risks posed by ...new therapeutic option comes up with the application of botulinum toxin in salivary ...mechanism of action ...
9
Expression of apoptosis-regulating genes in the rat prostate following botulinum toxin type A injection
... cycle of 12 ...Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals and with the European Communities Council Directive (86/609/ ...The use of animals was ...
7
Uso da toxina botulínica no tratamento de bruxismo crônico associado ao stress laboral = Chronic bruxism treatment of patients with work stress with botulinum toxin
... consisting of unconscious clenching and / or creaking of the ...effect of botulinum toxin type A (TxB-A) in the treatment of patients with chronic bruxism associated with labor ...
43
BOTULINUM TOXIN: FOR SAFE AND EFFECTIVE NON-SURGICAL TREATMENT IN ACUTE AND CHRONIC ANAL FISSURES
... risk of permanent sphincteric ...prolonged use. The use of ...effects of headache, local burning and development of ...[22] Botulinum toxin ...
4
Botulinum toxin type A versus botulinum toxin type B for cervical dystonia
... session of BtA and a single treatment session of BtB are equally effective and well tolerated in the treatment of adults with certain types of cervical ...rate of dysphagia and sore ...
45
Oral health effects of botulinum toxin treatment for droolling: a systematic review
... be of “some concerns” in relation to oral ...four of the five domains classified as “low risk of bias”, the fifth domain - bias in the selection of the reported results - was classified as ...
70
Comparison of different antibiotic protocols for asymptomatic bacteriuria in patients with neurogenic bladder treated with botulinum toxin A
... cases of symptomatic UTI were identified: five in the group that treated bacteriuria for more than three days ...frequency of symptoms for patients with clinical signs of infection, regardless ...
4
Poison as cure: a clinical review of botulinum toxin as an invaluable drug
... Botulinum toxin (BTX) is the most potent toxin known. It is readily absorbed from mucosal surfaces. Apprehensions have been expressed about its possible use as an agent in bioterrorism and ...
10
Mechanisms of action of botulinum toxin in the treatment of overactive bladder.
... strains of botulinum toxin only two, serotypes A and B, are commercially ...(Onabotulinum toxin A – Onabot/A, produced by Allergan Inc, Irvine, CA, USA), Dysport (Abobotulinum toxin A – ...
110